0001104659-23-061539.txt : 20230516
0001104659-23-061539.hdr.sgml : 20230516
20230516203328
ACCESSION NUMBER: 0001104659-23-061539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230514
FILED AS OF DATE: 20230516
DATE AS OF CHANGE: 20230516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehta Vimal
CENTRAL INDEX KEY: 0001733369
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38410
FILM NUMBER: 23929394
MAIL ADDRESS:
STREET 1: 780 EAST MAIN STREET
STREET 2: C/O BIOXCEL THERAPEUTICS, INC.
CITY: BRANFORD
STATE: CT
ZIP: 06405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001720893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821386754
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-643-8060
MAIL ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
tm2316022-3_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-05-14
0
0001720893
BioXcel Therapeutics, Inc.
BTAI
0001733369
Mehta Vimal
C/O BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, 12TH FLOOR
NEW HAVEN
CT
06511
0
1
0
0
CEO and President
0
Common Stock
2023-05-14
4
M
0
15000
A
30894
D
Common Stock
2000
I
By spouse
Restricted Stock Units
2023-05-14
4
M
0
15000
0
D
Common Stock
15000
0
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
On May 14, 2022, the Reporting Person was granted 15,000 RSUs that vested and settled on May 14, 2023.
This Form 4 does not include 8,546,750 shares of common stock previously reported as indirectly owned by the Reporting Person because the Reporting Person is not presently considered the beneficial owner of such shares.
/s/ Richard Steinhart, as attorney-in-fact for Vimal Mehta
2023-05-16